Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Rhythm · Phase 2 · Completed · Enrollment 213

NCT03013543

EudraCT 2017-000387-14

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
16p11.2 Cohort9 participants1 participants1 participantsn/r0
AS Cohort1 participants0 participants0 participantsn/r0
BBS Cohort3 participants2 participants2 participantsn/r0
MC4R Cohort12 participants7 participants7 participantsn/r1
POMC/PCSK1/LEPR Heterozygous Cohort14 participants4 participants3 participantsn/r0
POMC/PCSK1/LEPR Composite Heterozygous Cohort4 participants2 participants0 participantsn/r0
POMC/PCSK1/LEPR Compound Heterozygous Cohort13 participants6 participants1 participantsn/r0
SH2B1 Cohort13 participants6 participants4 participantsn/r0
SMS Cohort2 participants0 participants4 participantsn/r0
SRC1 Cohort11 participants4 participants1 participantsn/r0

A count stays a count. This page does not turn a count into a percent.